Covid-19: AstraZeneca to bring Dare-19 trial to India; 10 sites identified

Biopharmaceutical major AstraZeneca, which has undertaken a global research study to test the effects of drug dapagliflozin in preventing serious complications such as organ failure in Covid-19 patients, is likely to begin the trials in India by July end.

Called the Dare 19 trial, it is one of the several global research efforts by the British company to find a solution to treat Covid-19. Ten sites have already been identified for the study in India and the process is on to get approval from the Drugs Controller General of India for this.

“We hope to start the process by the